Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 3Thoracic 2Gastrointestinal 2Breast 2Sarcoma 1Genitourinary 1CNS 1

Conditions

Esophageal Neoplasms 10Carcinoma, Hepatocellular 10Rectal Neoplasms 9Colorectal Neoplasms 8Stomach Neoplasms 7Pancreatic Neoplasms 7Colonic Neoplasms 7Lung Neoplasms 6Breast Neoplasms 6Urinary Bladder Neoplasms 4Cholangiocarcinoma 4Carcinoma, Transitional Cell 4Salivary Gland Neoplasms 3Ovarian Neoplasms 3Neuroendocrine Tumors 3Liver Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Anus Neoplasms 3Adenocarcinoma Of Esophagus 3Uterine Cervical Neoplasms 2Tongue Neoplasms 2Thyroid Neoplasms 2Testicular Neoplasms 2Sarcoma 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2

Interventions

Cetuximab 3Fluorodeoxyglucose F18 2mercaptoundecahydrododecaborate 1fluoromisonidazole 1Zinc Oxide 1Tobacco Use Cessation Devices 1Rubidium-82 1Ritonavir 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Nicotine 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Indinavir 1Immunotherapy 1Immunohistochemistry 1FPP(RGD)2 1Everolimus 1Erlotinib Hydrochloride 1Drug Therapy 1Cyclophosphamide 1Cryosurgery 1Biopsy 1Biological Therapy 15-fluoropentyl-2-methylmalonic acid 14-boronophenylalanine-fructose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Tongue Neoplasms × Fluorodeoxyglucose F18 × Gastrointestinal × Clear all
NCT01806675 2019-10-03

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Stanford University

Phase 1/2 Completed
25 enrolled 14 charts
BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory, Gliosarcoma, Breast Neoplasms, Male

NCT01254591 2013-08-26

Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer

National Cancer Institute (NCI)

Phase NA Unknown
500 enrolled
BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lung Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡